Quick Answer
PSYENCE BIOMEDICAL LTD. reported R&D Expense of $342.2 thousand for fiscal year 2025.
PSYENCE BIOMEDICAL LTD. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $342.2K | -64.2% |
| 2024 | $954.6K | -40.7% |
| 2023 | $1.61M | — |
- PSYENCE BIOMEDICAL LTD. showed a decrease of -64.2% in R&D Expense compared to the prior fiscal year.
- Over the 2023–2025 period, PSYENCE BIOMEDICAL LTD.’s r&d expense has declined by 78.7% (from $1.61 million to $342.2 thousand).
- The most recent figure is from PSYENCE BIOMEDICAL LTD.’s fiscal year 2024 report (Form 20-F), filed with the SEC on June 25, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: